Recursion Pharmaceuticals Correlations

RXRX Stock

USD 4.60 0.01 0.22%

The current 90-days correlation between Recursion Pharmaceuticals and Agios Pharm is 0.21 (i.e., Modest diversification). The correlation of Recursion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Recursion Pharmaceuticals Correlation With Market

Good diversification

The correlation between Recursion Pharmaceuticals and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Recursion Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Recursion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Recursion Stock please use our How to Invest in Recursion Pharmaceuticals guide.

Moving together with Recursion Stock

0.69	DRMA	Dermata Therapeutics	Pair Corr
0.8	VINC	Vincerx Pharma Common	Pair Corr
0.71	VYGR	Voyager Therapeutics	Pair Corr
0.74	REVB	Revelation Biosciences	Pair Corr
0.64	AMRN	Amarin PLC	Pair Corr

Moving against Recursion Stock

0.56	HLN	Haleon plc	Pair Corr
0.44	LYEL	Lyell Immunopharma	Pair Corr
0.32	ERHE	ERHC Energy	Pair Corr
0.77	TRV	The Travelers Companies Sell-off Trend	Pair Corr
0.65	VZ	Verizon Communications Earnings Call This Week	Pair Corr
0.58	DD	Dupont De Nemours	Pair Corr
0.48	JNJ	Johnson Johnson	Pair Corr
0.46	PFE	Pfizer Inc Earnings Call This Week	Pair Corr
0.37	KO	Coca Cola	Pair Corr
0.35	BKKLY	Bangkok Bank PCL	Pair Corr

Related Correlations Analysis

	AGIO	DNLI	ETNB	BEAM	IBRX	RCUS	COGT	SRPT	GLPG	LQDA
AGIO		-0.45	-0.54	-0.43	-0.17	-0.71	-0.77	-0.16	-0.33	-0.74	AGIO
DNLI	-0.45		0.08	0.42	0.51	0.58	0.65	0.17	0.38	0.66	DNLI
ETNB	-0.54	0.08		0.67	0.38	0.2	0.44	0.34	0.71	0.67	ETNB
BEAM	-0.43	0.42	0.67		0.59	0.27	0.3	0.62	0.8	0.68	BEAM
IBRX	-0.17	0.51	0.38	0.59		0.05	0.19	0.18	0.64	0.58	IBRX
RCUS	-0.71	0.58	0.2	0.27	0.05		0.73	0.19	0.22	0.62	RCUS
COGT	-0.77	0.65	0.44	0.3	0.19	0.73		-0.02	0.37	0.78	COGT
SRPT	-0.16	0.17	0.34	0.62	0.18	0.19	-0.02		0.4	0.17	SRPT
GLPG	-0.33	0.38	0.71	0.8	0.64	0.22	0.37	0.4		0.69	GLPG
LQDA	-0.74	0.66	0.67	0.68	0.58	0.62	0.78	0.17	0.69		LQDA
	AGIO	DNLI	ETNB	BEAM	IBRX	RCUS	COGT	SRPT	GLPG	LQDA

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GLPG	+ 0.8	BEAM
LQDA	+ 0.78	COGT
COGT	+ 0.73	RCUS
GLPG	+ 0.71	ETNB
LQDA	+ 0.69	GLPG
LQDA	+ 0.68	BEAM

High negative correlations

COGT	- 0.77	AGIO
LQDA	- 0.74	AGIO
RCUS	- 0.71	AGIO
ETNB	- 0.54	AGIO
DNLI	- 0.45	AGIO
BEAM	- 0.43	AGIO

Risk-Adjusted Indicators

There is a big difference between Recursion Stock performing well and Recursion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Recursion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AGIO	3.17	(0.31)	0.00	(0.15)	0.00	0.00	5.99	(3.94)	56.88
DNLI	2.77	0.37	0.13	0.26	2.92	(3.26)	6.50	(4.21)	23.32
ETNB	2.99	0.84	0.34	0.36	1.83	(4.44)	3.02	(4.66)	86.02
BEAM	3.34	0.15	0.05	0.16	3.45	(4.20)	8.12	(6.28)	31.78
IBRX	5.13	1.61	0.33	1.74	4.20	(6.61)	11.16	(7.49)	51.87
RCUS	2.77	0.38	0.07	1.17	4.11	(2.94)	6.88	(6.93)	21.81
COGT	4.66	1.84	0.67	0.57	2.14	(6.56)	5.94	(4.44)	126.24
SRPT	3.77	0.01	0.01	0.07	6.81	(3.73)	7.34	(6.75)	37.95
GLPG	1.04	0.10	0.04	0.28	1.27	(1.08)	2.62	(2.52)	7.08
LQDA	2.89	1.01	0.27	2.85	3.01	(3.28)	8.00	(4.45)	19.63

Recursion Pharmaceuticals Corporate Management

Najat Khan	Chief Officer	Profile
Kevin Leggat	Vice Accounting	Profile
Janelle Gordon	Vice Operations	Profile
Shafique MD	Interim Officer	Profile
Lina Nilsson	Senior Platform	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC